8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide
Product Specifications
UNSPSC Description
8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide (compound 3), a sesquiterpene, has anti-LIMK1 activity. 8β,9α-Dihydroxylindan-4(5),7(11)-dien-8alpha,12-olide has inhibitory property on cell motility[1].
Target Antigen
LIM Kinase (LIMK)
Type
Natural Products
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/8β-9α-dihydroxylindan-4-5-7-11-dien-8alpha-12-olide.html
Solubility
10 mM in DMSO
Smiles
CC([C@H]1C[C@H]1[C@]([C@@H]([C@](O2)3O)O)4C)=C4CC3=C(C)C2=O
Molecular Weight
262.30
References & Citations
[1]Jianjiang Fu, et al. In vitro inhibitory properties of sesquiterpenes from Chloranthus serratus on cell motility via down-regulation of LIMK1 activation in human breast cancer. Phytomedicine. 2018 Oct 1;49:23-31.
Shipping Conditions
Room temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-N10868/8β-9α-Dihydroxylindan-4-5-7-11-dien-8alpha-12-olide-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-N10868/
Clinical Information
No Development Reported
CAS Number
956707-04-3
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![7-Chloro-1-methyl-5-phenyl-[1,2,4]triazolo[4,3-a]quinoline](https://cdn.genprice.uk/genprice/genprice4.png)